Sivextro 200 mg Tablets, Powder for solution for infusion

Sivextro 200 mg Tablets, Powder for solution for infusion

S4
PDF Leaflet Revision Date: July 2024

API: Tedizolid Phosphate | Company: Msd

Clinical Summary

Quick overview from the medicine insert

Indication

Used to treat skin and soft tissue infections in adults.

Dosage (summary)

200 mg IV infusion over 1 hour once daily for 6 days.

Special Populations

  • Children (< 18 years)
  • Renal impairment
  • Hepatic impairment

Pregnancy & Breastfeeding

Contraindicated in pregnancy and breastfeeding.

Key Drug Interactions

  • Tricyclics
  • SSRIs
  • MAOIs
  • Triptans
  • Methotrexate
  • Topotecan
  • Rosuvastatin

Contraindications

  • Allergy to tedizolid phosphate
  • Pregnancy
  • Breastfeeding

Common side effects

  • Nausea
  • Vomiting
  • Headache
  • Dizziness
  • Infusion site pain

Counselling Points

  • Do not drive if dizzy
  • Report diarrhea immediately
  • Consult before taking other medications

Serious warnings

  • Risk of serious blood cell effects with prolonged use
Important Disclaimer

The Sivextro 200 mg Tablets, Powder for solution for infusion professional information leaflet below is the property of Msd and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>

Healthcare Professionals Only

This content is for registered healthcare professionals

Sign in or create a free account to read the full package insert.

Free for HPCSA-registered professionals. Powered by Medinsert.

Successfully Stashed! 💊

This package insert has been safely stored in your digital medical cabinet. No prescription needed to view it later!

View My Favourites